CenterPoint Energy Files Additional Proxy Materials

TL;DR

CNP filed extra proxy docs, nothing major yet.

AI Summary

CenterPoint Energy Inc. filed a Definitive Additional Materials (DEFA14A) on April 6, 2026. This filing is related to proxy materials and does not contain specific financial details or proposals typically found in other SEC filings like 10-K or 10-Q. The filing is primarily for additional information to be provided to shareholders.

Why It Matters

This filing indicates that CenterPoint Energy is providing supplementary information to its shareholders regarding proxy matters, which could be relevant for upcoming shareholder votes or decisions.

Risk Assessment

Risk Level: low — This filing is procedural and does not contain new financial information or significant corporate actions that would immediately impact the company's risk profile.

Key Players & Entities

• CENTERPOINT ENERGY INC (company) — Filer
• 0001130310 (company) — CIK Number for CenterPoint Energy Inc.
• 2026-04-06 (date) — Filing Date

FAQ

Filing Documents

• tm2611040d1_defa14a.htm (DEFA14A) — 20KB
• tm2611040d1_defa14aimg01.jpg (GRAPHIC) — 11KB
• 0001104659-26-039732.txt ( ) — 36KB

From the Filing

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 14A Proxy Statement Pursuant to Section 14(a) of the Securities Exchange Act of 1934 (Amendment No. ) Filed by the Registrant Filed by a party other than the Registrant Check the appropriate box: Preliminary Proxy Statement Confidential, for Use of the Commission Only (as Permitted by Rule 14a-6(e)(2)) Definitive Proxy Statement Definitive Additional Materials Soliciting Material under § 240.14a-12 CenterPoint Energy, Inc. (Name of Registrant as Specified in its Charter) (Name of Person(s) Filing Proxy Payment of Filing Fee (Check all boxes that apply): No fee required Fee paid previously with preliminary materials Fee computed on table in exhibit required by Item 25(b) per Exchange Act Rules 14a-6(i)(1) and 0-11 On April 6, 2026, CenterPoint Energy, Inc. issued the following communication to its shareholders: Dear Valued Shareholder: On March 4, 2026, we filed our definitive proxy statement for the CenterPoint Energy, Inc. (“CenterPoint or the Company”) 2026 Annual Meeting of Shareholders, scheduled for April 16, 2026. In the proxy provision to CenterPoint’s Articles of Incorporation (as amended and restated, the “Charter”) and to make certain other immaterial updates. This is a narrowly tailored, common-sense update designed to address an imbalance between the treatment of directors and officers for a limited category of claims that was carefully crafted by our Corporate Governance and Nominating Committee to align with widely accepted practice while preserving accountability. What is limited officer exculpation? · Like most public companies, we have a provision in our Charter eliminating the personal liability of our directors for monetary damages for breach of the fiduciary duty of care. This is what is referred to as “exculpation.” · A recent amendment to Texas corporate law now allows a Texas corporation (like CenterPoint) to include a similar provision in its charter to exculpate officers for monetary damages for breach of the fiduciary duty of care in certain limited circumstances. · Delaware adopted similar provisions in its corporate law effective in August 2022, and according to Deal Point Data, since that time shareholders have approved officer exculpation charter provisions at over 650 Delaware public companies. · Like the existing director exculpation provision, the limited officer exculpation provision we are proposing would not exculpate officers from liability for breach of the duty of loyalty to the Company or its shareholders, acts or omissions not in good faith that constitute a breach of duty to the Company or that involve intentional misconduct or a knowing violation of law, any transaction in which the officer received an improper benefit, or an act or omission for which the liability of the officer is expressly provided by an applicable statute. · The Board also carefully crafted the limited officer exculpation provision so as not to apply to derivative claims – this approach is actually more limited than what Texas law permits, and is aligned with the familiar officer exculpation framework under Delaware law. Why is this important? · The Board believes limited officer exculpation strikes a balance between the interest in officer accountability and the Company’s ability to attract and retain highly qualified officers, addresses inconsistent treatment between officers and directors, and can decrease the Company’s future litigation and insurance costs. · Without an officer exculpation protection, individuals may be deterred from serving as officers due to exposure to personal liability and the risk of incurring substantial expense in defending lawsuits, regardless of merit. As noted above, over 650 public companies have recently adopted exculpation clauses that limit the personal liability of officers in their charters, and the Company expects that more public companies, including certain of the Company’s peers, will do so in the near future. The Board believes that failing to adopt the limited officer exculpation provision could therefore impact the Company’s recruitment and retention of exceptional officer candidates. · In recent years, plaintiffs have employed the tactic of bringing certain claims against officers that would otherwise be exculpated if brought against directors to avoid dismissal of such claims, extract settlement leverage, and/or increase settlement value. The Board believes that the limited officer exculpation provision can address inconsistent treatment between officers and directors and reduce future litigation and insurance costs. · Aligning the protections available to our officers with those available to our directors (with the exception of any derivative claims made by shareholders o

View Full Filing

View this DEFA14A filing on SEC EDGAR